Canadian MPN Research Foundation

What Canadian MPN Research Foundation does

The Canadian MPN Research Foundation (CMPNRF) is a CRA-registered Canadian charity founded in 2018 and headquartered in Toronto, with a stated mission to stimulate original Canadian research into myeloproliferative neoplasms (MPNs), a group of blood cancers including polycythemia vera, essential thrombocythemia, and myelofibrosis, in pursuit of new treatments and ultimately a cure. It serves MPN patients and caregivers, Canadian healthcare professionals, and Canadian MPN researchers through patient education, clinical trial referral facilitation, and a research grant program. Its first research grants were awarded in September 2023 to investigators at Sunnybrook Hospital, Jewish General Hospital, and Hôpital Maisonneuve-Rosemont.

CMPNRF's core offering is not a software product but an integrated digital platform centered on the cmpnrf.ca website, which hosts educational resources, an MPN glossary, a research milestones timeline, patient journey blogs, a clinical trial information and referral service (notably with Princess Margaret Cancer Centre), and the 'Beyond The Diagnosis' podcast launched in December 2024 with AbbVie support. Its research grant program funds work in MPN diagnostics and quality-of-life interventions. There is no proprietary technology stack disclosed; the foundation operates as a coordinating and funding entity rather than a product developer.

The foundation's business model is entirely donation-driven, with no fees for services. Revenue is generated through individual, corporate, and foundation donations channeled via the website donation portal, and the foundation is a CRA Registered Charity (#748799723 RR 001), making donations tax-deductible for Canadian donors. In March 2025, CMPNRF entered a strategic collaboration with the US-based MPN Research Foundation to co-fund research while retaining independent Canadian operations. The foundation has 1-10 employees and set a 2026 fundraising goal of CAD 200K or more to fund critical research.

Name

Canadian MPN Research Foundation

Legal name

Canadian MPN Research Foundation

Website

https://cmpnrf.ca

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

The Canadian MPN Research Foundation is a Toronto-based CRA-registered charity that funds Canadian research, education, and clinical trial access for patients affected by myeloproliferative neoplasm blood cancers.

Ownership category

akta.pro rank

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Markets served

Offering type

Services

Cost components

Others, Operations, Marketing or Sales, Personnel

Revenue model

1. Donations: The foundation operates primarily through charitable donations from individuals, corporations, and foundations. All donations are tax-deductible for Canadian donors. The foundation is a CRA Registered Charity (#748799723 RR 001).

Distribution channels1 record

Marketing channels9 records

Core offering

The Canadian MPN Research Foundation is a registered Canadian charity (CRA # 748799723 RR 001) that funds original Canadian research into myeloproliferative neoplasm (MPN) blood cancers, including polycythemia vera, essential thrombocythemia, and myelofibrosis. It awards research grants to Canadian investigators, provides patient and clinician education resources, disseminates clinical trial information, and runs the 'Beyond The Diagnosis' podcast series. All activities are funded through tax-deductible charitable donations.

Product overview

The Canadian MPN Research Foundation operates primarily as a digital platform and research funding organization rather than a traditional technology product company. The organization provides an information website (cmpnrf.ca) that serves as the central hub for patient education, research dissemination, and community engagement. Key offerings include the 'Beyond The Diagnosis' podcast series featuring Canadian patient stories and expert information, a research grant funding program supporting Canadian MPN researchers, clinical trial information and referral services for patients at Princess Margaret Cancer Centre, and extensive educational resources including an MPN glossary and research milestones timeline. The foundation also maintains a donations platform for fundraising purposes and provides blog-based patient journey content covering wellness tips, follow-up appointment guidance, and personal experiences with MPN conditions.

Differentiator

Problem solved

Functional benefit

Products and services

• Research Grant Program Funding program that awards grants to Canadian researchers studying MPN diagnostics, treatment, and patient quality of life, including spatial research techniques and physical activity programs.
• Beyond The Diagnosis: MPN Journeys with Patients & Experts Podcast Series Podcast series featuring personal stories from Canadian MPN patients and expert information on MPN topics.
• Clinical Trial Information & Referral Service Service providing information about clinical trials at Princess Margaret Cancer Centre and facilitating referrals for CALR mutated MPN patients through healthcare provider fax lines.
• Healthcare Professionals Resources Educational materials and resources for healthcare practitioners including MPN research reviews, expert talks, and clinical trial information.
• MPN Glossary Comprehensive medical glossary defining MPN-related terminology including genetic mutations (JAK2, CALR, MPL), treatment approaches, and clinical procedures.
• MPN Research Milestones Educational Resource Historical overview of MPN research milestones from 1951 to present, documenting key discoveries including JAK2V617F mutation (2005), CALR mutation (2013), and FDA approvals.
• Donations Platform Online donation system allowing supporters to contribute to MPN research funding, with tax receipt generation for Canadian donors.

Quantifiable outcome

• First Canadian MPN research grants awarded in 2023 to researchers at Sunnybrook Hospital, Jewish General Hospital, and Hôpital Maisonneuve-Rosemont

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core, supporting and minor.

• MPN Research Foundation (MPNRF)coreStrategic or Co-development Partner · 19 March 2025Strategic collaboration announced March 2025 focused on combining expertise and resources to fund and support research leading to new and better treatments and possible cures for MPNs. Both organizations will work together on key research-related projects while maintaining unique connections with patients and researchers in their respective countries. CMPNRF joins MPNRF's international funding efforts while retaining ability to separately fund Canadian-based research.
• AbbViesupportingGTM or Marketing PartnerAbbVie provided funding to support the 'Beyond the Diagnosis: MPN Journeys with Patients & Experts' podcast series produced by CMPNRF, featuring personal stories and expert information about MPNs in Canada.
• Bristol Myers Squibb CanadasupportingGTM or Marketing PartnerPartnered with Toronto Star on awareness campaign about myeloid cancers like MPNs, contributing to public education about these diseases in Canada.
• Princess Margaret Cancer CentrecoreStrategic or Co-development PartnerPrincess Margaret Cancer Centre shares clinical trial announcements with CMPNRF for dissemination to Canadian MPN patients. The MPN Program at Princess Margaret has invested heavily in infrastructure to facilitate clinical trials for CALR mutated MPN patients. CMPNRF helps facilitate patient referrals to these trials.
• Canadian MPN NetworksupportingGTM or Marketing PartnerPatient advocacy partner organization. CMPNRF shares Canadian MPN Network conference information and resources with its community. The 9th Canadian MPN Network National Conference featured collaboration on patient education.
• Clinical Outcomes SolutionsminorStrategic or Co-development PartnerHealthcare research company conducting a study to understand patients' experiences with myelofibrosis. CMPNRF shares information about this study with its patient community to facilitate participation.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Canadian Cancer Society: Canada's largest cancer charity funds research across all cancer types, including hematologic malignancies. Competes with CMPNRF for general donor dollars and research grant visibility in Canada.
• Leukemia & Lymphoma Society of Canada: LLSC is a larger Canadian nonprofit funding research across all blood cancers, including MPNs. Overlapping patient and researcher audiences make it a comparable incumbent in Canadian blood-cancer philanthropy.
• The Leukemia & Lymphoma Society (US): LLS is the largest US blood-cancer nonprofit funding research across leukemia, lymphoma, myeloma, and MPNs. It is the larger US analog and a model for how a blood-cancer nonprofit can scale research funding.

Emerging players

• CLL Society: CLL Society is a US patient-founded nonprofit dedicated to chronic lymphocytic leukemia education, support, and research funding. Comparable small-team, disease-specific structure targeting a hematologic malignancy community.
• Blood Cancer United (formerly Leukemia Research Foundation): Blood Cancer United funds research across all blood cancers and provides patient support. Smaller than LLS, it represents a mid-scale US peer focused on hematologic malignancy research grants and patient education.
• Myeloma Canada: Myeloma Canada is a disease-focused nonprofit supporting patients with another hematologic malignancy (multiple myeloma) and funding Canadian research. Similar patient-education and grant-funding model, comparable size.
• Lymphoma Canada: Lymphoma Canada is a small Canadian nonprofit providing patient education, support, and research funding for lymphoma. Operates with a comparable small-team, disease-specific model targeting Canadian hematology patients.

Direct peers

• MPN Research Foundation: The US-based MPN Research Foundation is CMPNRF's closest counterpart and now formal strategic ally. Both are patient-founded nonprofits exclusively funding original MPN research, sharing mission, disease focus, and patient-researcher engagement model.

Others

• Princess Margaret Cancer Foundation: PMCF is the fundraising arm of Princess Margaret Cancer Centre, a Canadian hospital-based research foundation. It is a direct partner of CMPNRF for clinical trial referrals and a structural model for hospital-affiliated research philanthropy.

Regional players

• International Myeloma Foundation: IMF is a US-based patient-founded nonprofit funding myeloma research globally. While disease focus is narrower than CMPNRF's, the patient-founded, research-grant-driven model is structurally similar.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key highlights7 records

Customer concentration

• Xtwitter.com/canadianmpn?lang=en
• YouTubeyoutube.com/results?search_query=canadian+mpn+research+foundation
• Facebookfacebook.com/cmpnrf
• LinkedInlinkedin.com/company/canadian-mpn-research-foundation

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canadian MPN Research Foundation